Humana (NYSE:HUM – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $16.00 for the period, compared to the consensus estimate of $16.34.
Humana Stock Up 1.3 %
Shares of Humana stock traded up $4.64 during trading hours on Friday, hitting $363.62. 1,076,306 shares of the company’s stock traded hands, compared to its average volume of 1,396,067. The stock has a 50 day simple moving average of $367.90 and a 200-day simple moving average of $347.35. The company has a quick ratio of 1.67, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The company has a market cap of $43.78 billion, a PE ratio of 22.64, a PEG ratio of 2.09 and a beta of 0.51. Humana has a twelve month low of $298.61 and a twelve month high of $530.54.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company’s revenue was up 10.4% on a year-over-year basis. During the same period last year, the firm earned $8.94 earnings per share. Equities research analysts anticipate that Humana will post 16.14 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on Humana
Humana Company Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
- Five stocks we like better than Humana
- What Are Dividend Challengers?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- How to Calculate Return on Investment (ROI)
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.